Monitoring touchpoints to build into your protocol: Baseline labs and clinical assessment before initiation Follow-up at 4-6 weeks to review tolerability and dosing Progress check at 3 months with reassessment of the care plan Ongoing monitoring as clinically appropriate Be direct with patients: the goal is sustainable weight management, not rapid results
It is the first peptide that simultaneously activates three key receptors: GLP-1, GIP, and glucagon
Critical Reviews in Food Science and Nutrition, 59(16), 26882696
GLP-1 treatment was not statistically significantly different compared to control at reducing the risk of developing dry AMD at one and three years after treatment, but GLP-1 receptor agonists did lower dry AMD risk at five and 10 years after treatment by 9.2% and 14.9%, respectively
Why Microdosing Works Better for Longevity Minimized Side Effects : Nausea, vomiting, constipation, and fatigue are common at higher doses
Overall safety takeaways for bodybuilders: Side effects tend to be dose-dependent and reversible once the peptide is discontinued